Clinical significance of homologous recombination deficiency (HRD) score testing in endometrial cancer patients.

被引:2
|
作者
Hansen, Jean M.
Ring, Karl Lassen
Baggerly, Keith A.
Wu, Sherry
Timms, Kirsten
Neff, Christopher
Hughes, Elisha
Previs, Rebecca A.
Broaddus, Russell
Coleman, Robert L.
Lu, Karen H.
Sood, Anil
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[2] Myriad Genetics Inc, Salt Lake City, UT USA
关键词
D O I
10.1200/JCO.2016.34.15_suppl.5584
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5584
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Streamline of the gene line: Implementation of reflex homologous recombination deficiency (HRD) tumor testing in newly diagnosed ovarian cancer patients
    Byrne, Maureen
    Mckenna, Danielle
    Schumacher, Ryan
    Shah, Payal
    Mastroyannis, Spyridon Alexandros
    Lodise, Amy
    Oliver, Sirithepphavanh
    Schwartz, Lauren
    Martin, Lainie
    Domchek, Susan
    Haggerty, Ashley
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S287 - S288
  • [22] Clinical-genomic characteristics of homologous recombination deficiency (HRD) in breast cancer: application model for practice
    Du, Jinsui
    Zhu, Lizhe
    Duan, Chenglong
    Ma, Nan
    Zhou, Yudong
    Li, Danni
    Zhang, Jianing
    Zhang, Jiaqi
    Wang, Yalong
    Liu, Xi
    Ren, Yu
    Wang, Bin
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2025, 30 (01)
  • [23] Analysis of homologous recombination deficiency (HRD) scores in osteosarcoma
    Kinnaman, Michael David
    Pena, Julia
    Levine, Max
    Bouvier, Nancy
    Papaemmanuil, Elli
    Forrest, Suzanne
    Janeway, Katherine
    Meyers, Paul
    Bender, Julia Glade
    CANCER RESEARCH, 2022, 82 (12)
  • [24] Radiogenomics of homologous recombination deficiency (HRD) in breast cancer: Radiomics-based image biomarker for HRD
    Lim, Joonoh
    Paik, Pill Sun
    Lee, Jeongmin
    Oh, Brian Baek-Lok
    Kim, Ryul
    Ju, Young Seok
    Lee, Jeong Seok
    Kwon, Minsuk
    Lee, Sangmoon
    Lee, Won-Chul
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [25] ctDNA from ascites as an alternative to tumor sampling for HRD (homologous recombination deficiency) testing in ovarian cancer (OC).
    Leary, Alexandra
    el Hazzaz, Reda
    Le Formal, Audrey
    Lecerf, Elodie
    Brizais, Chloe
    Blameble, Emeline Colomba
    Gouy, Sebastien
    Maulard, Amandine
    Boursin, Yannick
    Pautier, Patricia
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [26] The development of a homologous recombination deficiency (HRD) score to identify HR-deficient tumors.
    Wu, Xiaohua
    Wen, Hao
    Feng, Zheng
    Shao, Lin
    Liu, Chenglin
    Liu, Hao
    Zhang, Lu
    Mao, Xinru
    Guan, Xiaoqian
    Hou, Ting
    Han Han-Zhang
    Zhang, Zhou
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [27] Homologous recombination deficiency (HRD) score in germline BRCA2- versus ATM-altered prostate cancer
    Lotan, Tamara L.
    Kaur, Harsimar B.
    Salles, Daniela C.
    Murali, Sanjana
    Schaeffer, Edward M.
    Lanchbury, Jerry S.
    Isaacs, William B.
    Brown, Robert
    Richardson, Andrea L.
    Cussenot, Olivier
    Cancel-Tassin, Geraldine
    Timms, Kirsten M.
    Antonarakis, Emmanuel S.
    MODERN PATHOLOGY, 2021, 34 (06) : 1185 - 1193
  • [28] Homologous Recombination Deficiency (HRD) Score in Germline BRCA2-Versus ATM-Altered Prostate Cancer
    Kaur, Harsimar
    Salles, Daniela
    Murali, Sanjana
    Lanchbury, Jerry
    Isaacs, William
    Brown, Robert
    Richardson, Andrea
    Cussenot, Olivier
    Cancel-Tassin, Geraldine
    Timms, Kirsten
    Antonarakis, Emmanuel
    Lotan, Tamara
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 575 - 576
  • [29] Homologous Recombination Deficiency (HRD) Score in Germline BRCA2-Versus ATM-Altered Prostate Cancer
    Kaur, Harsimar
    Salles, Daniela
    Murali, Sanjana
    Lanchbury, Jerry
    Isaacs, William
    Brown, Robert
    Richardson, Andrea
    Cussenot, Olivier
    Cancel-Tassin, Geraldine
    Timms, Kirsten
    Antonarakis, Emmanuel
    Lotan, Tamara
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 575 - 576
  • [30] Detection of molecular signatures of homologous recombination deficiency in endometrial cancer
    Cheng, Xiaqin
    Qiu, Ya
    Zeng, Zhen
    Wei, Wei
    Li, Jundong
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S104 - S104